The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


FDA grants priority review for Lynparza for maintenance setting in ovarian cancer patients.....           Could Sandoz have stalled Mylan's generic Advair? Maybe so, analyst says, citing FDA post.....           Mylan's $465M settlement shortchanges taxpayers: study.....           Revving up for new Tesaro rival, AstraZeneca nabs quick FDA review for bigger Lynparza use.....           Ex-Valeant skipper Pearson claims he's owed $30M-plus in unpaid severance, consulting fees.....           Vertex to shutter Canada site, focus in on 3 hubs in R&D shuffle.....           Second time's the charm? Pfizer tries again with OTC Viagra in the U.K......           Sanofi, Regeneron ready to roll with $3B-plus Dupixent approval.....           Pfizer Men B shot Trumenba wins EU committee's backing.....           Allergan, Paratek?s acne drug succeeds in two phase 3 trials.....           Summit to extend PhaseOut DMD trial for ezutromid.....           University of Dundee secures grant to discover new antibacterial drugs.....           FDA approves Tesaro?s Zejula for recurrent ovarian cancer.....           Roche's much-anticipated MS game-changer, Ocrevus, nabs its FDA green light.....           DTC #FierceMadness comes down to Elite Eight, with ?God,? Superheroes and Aniston still in the hunt.....           Serelaxin's demise ups the stakes on Novartis' latest Entresto-boosting moves.....           Gilead's Sovaldi patent under fire again from MSF coalition, this time in Europe.....           Alexion brings on former Baxalta chief Hantson to fill vacant CEO spot.....           Can ex-Actavis CEO Paul Bisaro work his growth magic at Impax?.....           Stada CEO discovers he's under surveillance as deal action heats up.....           Beleaguered Insys spending $24M on manufacturing expansion.....           Allergan's CEO pay plummets by 80% without big M&A and strong financials.....           Tesaro puts AstraZeneca on notice with early FDA nod for Lynparza rival niraparib.....           Genentech's Rituxan gets FDA breakthrough therapy status to treat pemphigus vulgaris.....           Xenon?s acne drug XEN801 fails in phase 2 trial.....           PureTech signs licensing and equity deal with Novartis to advance clinical stage mTORC1 programs.....           Ignyta to explore strategic options for cancer candidate taladegib.....           Sanofi reviews consumer health business media buying and planning account post-Boehringer swap.....           J&J looks for the inside story with new online psoriasis campaign.....           FiercePharmaAsia?China?s foreign drug policy, Tessa?s deal, two Big Pharma chiefs? globalization comments.....           Purdue and Shionogi's new constipation approval goes up against AZ, Valeant rivals.....           Merck, Pfizer get FDA nod for Bavencio to treat metastatic Merkel cell carcinoma.....           BioLineRx acquires UK cancer immunotherapeutics company Agalimmune.....           Amgen?s Amgevita secures approval in Europe for certain inflammatory diseases.....           Struggling Teva said to plan thousands of job cuts as it hunts for CEO.....           Lawmakers want to know PTC's pricing plans for ex-Marathon drug Emflaza.....           Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source.....           It's not just lower U.S. drug prices Trump wants. He wants the lowest, period.....           Valeant awarded CEO Papa $62.7M last year despite missing financial targets.....           Pfizer CEO Read: Healthcare overhaul needs to 'get the incentives right'.....           Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy Bavencio.....           Novartis? serelaxin fails to meet primary endpoint in heart failure study.....           GSK, Regeneron to mine gene data from 500000 volunteer participants in UK.....           Akashi gets FDA nod to restart clinical development of DMD drug HT-100.....           Biogen wins patent ruling in multiple sclerosis drug case.....           DTC #FierceMadness hits the Sweet 16 as Gut Guy, Irritabelle and show tunes bite the dust.....           FDA's orphan drug program under GAO scrutiny after senators allege abuse.....           FDA signs off on Parkinson's add-on drug Xadago.....           Biogen sticks it to Kyle Bass with Tecfidera IPR win.....           Sanofi exec fires back amid fight over Zika vaccine license.....           Newron?s Xadago gets FDA nod to treat Parkinson?s disease.....           X-Chem, Ono to collaborate on multi-target drug discovery.....           Pierre Fabre, H-Immune partner on immuno-oncology therapeutics.....           J&J taps Hannibal Buress to convince millennials to 'give a spit' about bone marrow donation.....           Novartis star Cosentyx, facing new rivals, may gain edge as a disease-modifying med.....           Eli Lilly says it's cutting an average of 50% off list prices?and its price hikes don't work.....           Lilly CEO Ricks in China: Free trade good, antiglobalization moves 'dangerous'.....           Heads up, pharma. Trump's pushing GOP to put 'competitive bidding' on drugs in healthcare bill.....           Copying Valeant's Xifaxan just got 'a lot easier,' thanks to new FDA guidance: analyst.....           Emergent touts new $100M delivery order for BioThrax.....           Sanofi, Regeneron ask court to shield Dupixent from Amgen patent attack.....           Bristol-Myers Squibb, CytomX extend cancer collaboration.....           SalvaRx to invest in Rift Biotherapeutics.....           Nektar?s NKTR-181 shown to reduce chronic pain in phase 3 trial.....           Lilly?s abemaciclib meets primary endpoint in phase 3 breast cancer trial.....           Pharma's rep with patient groups was on the rise, but not anymore: PatientView.....           The ACC skinny: Amgen's PCSK9 outcry, AZ's SGLT2 death cuts, Xarelto's aspirin beat.....           China proposes new FDA rules to speed up foreign drug approvals.....           J&J chief Gorsky, in China for official summit, straddles Trump's globalism divide.....           SutroVax reels in $64M with plans to take on $7B pneumococcal vaccine market.....           Amgen's Repatha lowers heart attack, stroke risk in phase 3 study.....           Novartis? heart failure drug Entresto improves glycemic control in Phase III study.....           Circassia signs deal for US rights to two AstraZeneca COPD drugs.....           Oxford BioDynamics participates in rheumatoid arthritis triggers study.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
PharmSci 2017 - first announcement

Tuesday 5 - Thursday 7 September 2017 at De Havilland Campus, University of Hertfordshire, Hatfield

The theme of the conference in 2017 is:
'Pharmaceutical Science without Borders'

The APS is pleased to announce Professor Abdul Basit as this year's Conference Science Chair.

Professor of Pharmaceutics at the School of Pharmacy, University College London, where he leads a research group investigating drug delivery to the gastrointestinal tract.

"I am delighted to be Chairing the 8th APS International PharmSci Conference 2017 at the University of Hertfordshire, where our focus this year is "Pharmaceutical Science without Borders". Pharmaceutical science transcends a multitude of borders - it is very much an international field, collaborative in nature and underpins medicines development. The healthcare challenges we face today are global, and cannot be addressed in isolation. Our aim in this conference is to connect, empower and inspire those of you across the pharmaceutical sciences sector and beyond; to broaden your research goals and horizons alongside showcasing pragmatic approaches to trouble-shooting/problem-solving in the pharmaceutical sciences. I look forward to welcoming you to what will no doubt be a fascinating and intellectually stimulating event."

You can become part of this conference now.

Reserve the date, suggest a topic, offer a poster presentation, reserve an exhibition space and many other opportunities. Please email info@apsgb.org.

Please also regularly check the PharmSci website for updates.
 

PharmSci 2016 Conference - Chair's review

The Chair of the Academy of Phamaceutical Sciences, Dr Linda Hakes, gives a brief review of the 7th APS International PharmSci Conference, held in Glasgow on 5-7 September 2016.

"2016 has come to an end and although I admit that I am probably biased, I think it was a fantastic three days. The venue, the Technology and Innovation Centre at Strathclyde University, was well equipped to handle the conference and the facilities are modern and efficient.

All of the conference sessions (as far as I could tell) were well attended and the plenary lectures were all excellent, covering topics ranging across the spectrum of pharmaceutical sciences, embracing chemistry, pharmacology, medical devices, formulation, pharmacokinetics and spectroscopy.

A highlight of the social side was the Civic Reception in the City Chambers, a magnificent building on George Square, where we were warmly welcomed by the Bailey Steward on behalf of the Lord Provost of Glasgow.

 

 

 

 

 

As always the Black Tie Dinner was a great success and we were pleased to have Prof. Sandy Florence as guest speaker. Again, the venue was truly impressive – the Barony Hall.

 

 

 

 


To sum up, I believe we enjoyed a conference full of good science, excellent networking opportunities, and highly enjoyable social events. If you weren’t there, why not make a note for next year –
Tuesday 5 - Thursday 7 September 2017 at the University of
Hertfordshire .

See you there!"

Latest News
APS 8th International PharmSci Conference 2017 Call for Abstracts
THURSDAY, 12 JANUARY 2017
. 'Pharmaceutical Sciences Without Borders’. Tuesday 5 – Thursday 7 September 2017 De Havilland Campus of the University of Hertfordshire in Hatfield. Call for Abstracts. Abstracts are invited for posters for APS International PharmSci 2017. This is one of the most exciting parts of the conference as it represents the presentation of the very latest pharmaceutical science research.. Abstracts on any aspect of the Pharmaceutical Sciences are welcomed and those with a particular emphasis on the theme of this year’s Conference, 'Pharmaceutical Sciences Without Borders’ are particularly appreciated. Details of the various subject categories, an abstract template and details of the entry process can be found here:. http://www.ukpharmsci.org/abstracts/default.asp. Please ensure abstracts are submitted online and comply with the Abstract Submission Template. Please note one or two page abstracts are welcomed providing they follow the template.. There will be prizes awarded for winning posters on each day of the Conference and authors of abstracts of particular interest will be invited to give podium presentations (15min). This is an excellent chance to get your science recognised at the UK’s premier Pharmaceutical Science Conference. The closing date for abstract submission is Friday 17th March 2017.. Abstracts will be made available to Conference registrants when the abstract author has registered for the Conference. We also intend to publish the abstracts in a journal after the Conference and authors not wishing to take up this opportunity are requested to indicate this where indicated when they submit their abstract.. Entrants in the Analytical Chemistry category may be eligible for the Geoffrey Phillips Analytical Science Award, subject to meeting the criteria, awarded by the Joint Pharmaceutical Analysis Group (JPAG). The purpose of the Award is to encourage the advancement of pharmaceutical analysis and to recognise contributions of emerging scientists reporting wholly or mainly their own work. The winner receives a prestigious award with a bursary of up to £1000 to attend a conference relevant to their area of interest.. http://www.jpag.org/?&sid=20170112135948802597&p=awards#award. Exhibitor Opportunities. The conference includes a large pharmaceutical sciences exhibition, which is open to large pharma companies, small and medium size enterprises (SMEs), contract research organisations (CROs) and technology suppliers. With one of the largest gatherings of pharmaceutical scientists in the UK, the conference offers a great opportunity to showcase your company.. For more information please contact us: info@apsgb.org or 0116 274 7351. .
APS Fellowships Announcement 2017
WEDNESDAY, 2 NOVEMBER 2016
Do you know someone who has made a significant contribution to Pharmaceutical Science?. The APS is calling for nominations of candidates to become Fellow or Eminent Fellow of the Academy of Pharmaceutical Sciences.. Nominees for Fellowship must be a member of APS (for at least one year) and have a proven track record in pharmaceutical science, as demonstrated by at least 15 peer-reviewed publications, patents or equivalent. This would include significant contributions to the development of products or medical devises within the pharmaceutical industry. Nominees must also have demonstrated leadership and peer recognition through invited lectures, conference leadership, mentoring of young scientists etc. Candidates may self-nominate and nominations must consist of a one-page summary of achievements accompanies by a CV.. Nominations for Eminent Fellowship may be submitted by any member of APS but self-nominations are not accepted. Nominees for Eminent Fellowship must have international recognition for their advocacy of science and have demonstrated leadership at international level. Nominations should consist of a one-page summary of achievements and an explanation of why Eminent Fellowship is justified, and be accompanied by a CV.. Nominations should be sent to info@apsgb.org by 1 March 2017.
APS 8th International PharmSci Conference 2017
TUESDAY, 1 NOVEMBER 2016
. Tuesday 5 - Thursday 7 September 2017 De Havilland Campus, University of Hertfordshire, Hatfield. The theme of the conference in 2017 is. 'Pharmaceutical Science without Borders'. The APS is pleased to announce Professor Abdul Basit as the Conference Science Chair Professor of Pharmaceutics at the School of Pharmacy, University College London, where he leads a research group investigating drug delivery to the gastrointestinal tract.. “I am delighted to be Chairing the 8th APS International PharmSci Conference 2017 at the University of Hertfordshire, where our focus this year is “Pharmaceutical Science without Borders”. Pharmaceutical science transcends a multitude of borders – it is very much an international field, collaborative in nature and underpins medicines development. The healthcare challenges we face today are global, and cannot be addressed in isolation. Our aim in this conference is to connect, empower and inspire those of you across the pharmaceutical sciences sector and beyond; to broaden your research goals and horizons alongside showcasing pragmatic approaches to trouble-shooting/problem-solving in the pharmaceutical sciences. I look forward to welcoming you to what will no doubt be a fascinating and intellectually stimulating event.”. . You can become part of this conference now,. Reserving the date, suggest a topic, offer a poster presentation, reserve an exhibition space and many other opportunities. Please email info@apsgb.org.. . . . . . .
APS thanks retiring Board members and welcomes Yvonne Perrie and Michael Leane as newly appointed Board members
TUESDAY, 4 OCTOBER 2016
At the AGM on 5 September, held during the PharmSci conference at the Technology and Innovation Centre at Strathclyde University, we formally thanked our two retiring Board members, Richard Storey and Claire Thompson, for all their hard work and support of APS over several years of service. Claire has been an enthusiastic Board member who has been a strong advocate for pharmaceutical science and has been very engaged in outreach to universities, students and young scientists. Richard Storey has served not only as a Board member but has also been our Treasurer for many years, a task which has had many challenges which he has managed in a calm and professional manner. We are very grateful to both of them and hope that they will remain active members and supporters of APS.. . At the AGM we also ratified the selection of Yvonne Perrie (Strathclyde University) and Michael Leane (BMS) as the incoming Board members. We warmly welcome them to the Board and look forward to working with them.
Follow us
 
Upcoming Events
APS Industrial Insights 2017
20 - 21 April 2017
APS Board and Advisory Board Meeting
12 July 2017
APS 8th International PharmSci Conference 2017
5 - 7 September 2017
APS Advances in Amorphous Design, Control and Delivery of Amorphous and Co-amorphous Pharmaceutical Materials
3 October 2017
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351
Fax: 0116 274 7365
Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.